Planar Systems and U.S. Electronics, a distributor of Totoku medical-grade monitors, have been cleared by the FDA to market certain high-performance flat-panel displays for the diagnostic reading of mammography images. Planar is now able to market the
Planar Systems and U.S. Electronics, a distributor of Totoku medical-grade monitors, have been cleared by the FDA to market certain high-performance flat-panel displays for the diagnostic reading of mammography images. Planar is now able to market the Dome C5i system for this application. U.S. Electronics can market the Totoku ME511L LCD. Both products offer five-megapixel displays.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.